Medical Supply

Medical Supply Chain Management

Overview

A comprehensive web-based information system for pharmaceutical supply chain management, tracking medicines from production to end consumer.

Medicines move through a supply chain with several participants: manufacturers, wholesalers, and retailers. They are engaged in the production, transportation, and sale of these products. A key participant in these systems is the regulating authority responsible for each stage of the movement of batches of products throughout the chain. At the state level, this is often an authorised body such as an Agency for the Control of Turnover of Medicinal Products.

Project Goals
1
Design and build a web application for medical supply chain management
2
Support registration of drug types, issuance and lifecycle of licenses
3
Track medicine units with a unique code (UUID) from creation to end consumer
4
Enable ownership transfer along the chain (Manufacturer → Pharmacy → Citizen) with full audit history
5
Provide role-based web dashboards for Government, Manufacturer, and Pharmacy, and a public verification page for citizens
6
Ensure the system is auditable, secure, and aligned with regulatory expectations

Participants in the System

Government

Regulator / Administrator

Manufacturer

Producer

Pharmacy

Retailer / Dispenser

Doctor

Prescriber (Phase 2)

Citizen

End Consumer

High-Level Flow
1

Government

Registers drug type & issues production license

2

Manufacturer

Creates medicine units (UUID), transfers to pharmacy

3

Pharmacy

Receives units, transfers to citizen when selling

4

Citizen

Verifies authenticity via UUID in public portal

Strengths & Limitations

Strengths

  • Centralised, web-accessible system for drug registration, licensing, and unit tracking
  • Full audit trail of ownership transfers with timestamps
  • Public verification by UUID supports transparency and consumer trust
  • Role-based access keeps data and actions appropriate to each participant

Limitations

  • Tracks only movement along official supply chains known to the regulator
  • Cannot track counterfeit drugs distributed outside those chains
  • Real-world performance depends on deployment and integration